Portfolio company
Metabogen
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops microbiome-based probiotics and pharmaceuticals for the probiotic and pharmaceutical industries to treat various health conditions.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Holobiome
This company develops probiotics and microbiome-based therapies for pharmaceutical, food and consumer health partners to improve conditions like depression, stress and pain.
mbiomics
This company develops live bacterial therapeutics and a microbiome profiling platform to treat patients with cancer and inflammatory bowel diseases.
Florey Biosciences
This company develops engineered probiotics for patients taking antibiotics to protect gut microbiome health and prevent related medical conditions.
KOBIOLABS
This company develops microbiome-derived therapeutics and live biotherapeutic products for patients with immune, metabolic, neurological and gastrointestinal diseases.
MRM Health
This biopharmaceutical company develops microbiome-based live biotherapeutic products for patients with chronic inflammatory diseases and immune-oncology conditions.
Human Biome
This biotechnology firm develops gut microbiota-based biotherapeutics and fecal microbiota transplantation preparations for medical professionals treating gastrointestinal infections and antibiotic resistance.
BIOHM Health
This company develops microbiome testing kits and probiotic supplements for consumers and provides microbiome data services for food and beverage organisations.
EnteroBiotix
This biopharmaceutical company develops orally administered microbial therapeutics for patients with gastrointestinal diseases, including irritable bowel syndrome and blood cancers.
